A Novel and Versatile Adjuvant Biologic Therapy in the Management of Neuropathies

In mammals, axons of injured peripheral nerves (PNI) can and do regenerate, but often the functional recovery is incomplete or suboptimal. In recent years in vivo tissue engineering approaches through molecular intervention and scaffolding are offering promising outcomes.